Resources and Industry Insights
Life Sciences Resources for Drug, Biologic, and Combination Product Development
Explore articles, webinars, videos, courses, and technical resources from Pharmatech Associates.
Filter

Developing a Biosimilar Candidate
Developing a Biosimilar Candidate

What the Biosimilars Industry Is Really Saying Right Now
What the Biosimilars Industry Is Really Saying Right Now

Cell and Gene Therapy: Opportunities and Risks for Manufacturers
Cell and Gene Therapy: Opportunities and Risks for Manufacturers

Navigating Regulatory Considerations for Pharma Startups
Navigating Regulatory Considerations for Pharma Startups

Quality vs. Compliance in Pharma: Understanding the Difference
Quality vs. Compliance in Pharma: Understanding the Difference

How to Craft and Maintain a Robust Data Integrity Program
How to Craft and Maintain a Robust Data Integrity Program

Optimizing Your mAb Program: Proven Strategies for Success
Optimizing Your mAb Program: Proven Strategies for Success

Mastering Quality – Building a Strong Foundation for Your Pharma Startup
Mastering Quality – Building a Strong Foundation for Your Pharma Startup

How to Increase Efficiency in Cell & Gene Therapy Research
How to Increase Efficiency in Cell & Gene Therapy Research

Is Your Quality Management System (QMS) Keeping Up?
Is Your Quality Management System (QMS) Keeping Up?

Quality Considerations for Aseptic Processing
Quality Considerations for Aseptic Processing

Applying Process Analytical Technology (PAT) to Support Real Time Release (RTR)
Applying Process Analytical Technology (PAT) to Support Real Time Release (RTR)
Filter

60% More Yield From the Same Purification Train
60% More Yield From the Same Purification Train

A 200,000× Leap With No Room for Error
A 200,000× Leap With No Room for Error

Comprehensive Assessment Leads to FDA Alignment
Comprehensive Assessment Leads to FDA Alignment

Redevelopment Success Without FDA Findings
Redevelopment Success Without FDA Findings

Eight Programs Transferred Without Delay
Eight Programs Transferred Without Delay

Dual Pathway Strategy Shortens Approval Timeline by Six Months
Dual Pathway Strategy Shortens Approval Timeline by Six Months

Approval Accelerated by 3 to 6 Months Through Smarter CMC Strategy
Approval Accelerated by 3 to 6 Months Through Smarter CMC Strategy

Six Months to Fast-Track Approval Through Risk-Based CMC
Six Months to Fast-Track Approval Through Risk-Based CMC

Ending 18 Months Off Market
Ending 18 Months Off Market

Faster Market Entry Through Smarter Strategy
Faster Market Entry Through Smarter Strategy

Quality System Remediation Drives Combination Product Readiness
Quality System Remediation Drives Combination Product Readiness

Closing CMC Gaps to Keep a BLA on Schedule
Closing CMC Gaps to Keep a BLA on Schedule
Filter

Biosimilars: Meeting the FDA with Your Biosimilar Product
Biosimilars: Meeting the FDA with Your Biosimilar Product

Model-Informed CMC Development of Amorphous Solid Dispersions Using Continuous Melt Extrusion
Model-Informed CMC Development of Amorphous Solid Dispersions Using Continuous Melt Extrusion

From Experiment to Accepted: How In-Silico is Redefining CMC with Regulatory Confidence
From Experiment to Accepted: How In-Silico is Redefining CMC with Regulatory Confidence

Solving CGT Manufacturing: Control Strategy as the Key
Solving CGT Manufacturing: Control Strategy as the Key

Quality Considerations for a Robust Data Integrity Program
Quality Considerations for a Robust Data Integrity Program

Entering the U.S. Market: What Does it Take?
Entering the U.S. Market: What Does it Take?

mAbs: Biosimilars from Lab to Clinical
mAbs: Biosimilars from Lab to Clinical

Mastering Quality – Building a Strong Foundation for Your Pharma Startup
Mastering Quality – Building a Strong Foundation for Your Pharma Startup

Modern Approaches to mRNA Manufacturing
Modern Approaches to mRNA Manufacturing

Modern Quality Techniques: Patient Centric Processes, Integrated QMS, Regulatory Intelligence


